TransMedics (TMDX) Equity Ratio (2018 - 2026)

TransMedics has reported Equity Ratio for 9 years, with the latest figure at 0.34 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio rose 8.28% year-over-year to 0.34; the trailing twelve-month figure through Mar 2026 stood at 0.34 (up 8.28% YoY), and the FY2025 full-year result was 0.44, up 55.76% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.34, down from 0.44 in the prior quarter.
• The five-year high for Equity Ratio was 0.68 in Q3 2022, with the low at 0.18 in Q3 2023.
• Average Equity Ratio over 5 years is 0.38, with a median of 0.34 recorded in 2026.
• Year-over-year, Equity Ratio slumped 73.15% in 2023 and surged 55.76% in 2025.
• Tracing TMDX's Equity Ratio over 5 years: stood at 0.68 in 2022, then sank by 71.26% to 0.19 in 2023, then jumped by 46.3% to 0.28 in 2024, then soared by 55.76% to 0.44 in 2025, then declined by 22.25% to 0.34 in 2026.
• The last three Equity Ratio figures came in at 0.34 (Q1 2026), 0.44 (Q4 2025), and 0.38 (Q3 2025), per Business Quant data.

Peer Comparison